Expression of inducible heat shock protein 70 (HSP70) in tumor cells has been proposed to enhance their immunogenicity. However, HSP70 has also been demonstrated to prevent tumor cell death, a key process for the development of tumor cell immunogenicity. In the present study, we investigated the in¯uence of the HSP70 protein level on PRO colon cancer cell growth and immunogenicity in syngeneic BDIX rats and nude mice. These cells have a basal expression of HSP70 which can be substantially increased by heat shock. When injected subcutaneously in syngeneic animals, PRO cells do not induce any detectable immune response and give rise to progressive, metastatic and lethal tumors. Stable transfection of an anti-sense hsp70 cDNA in PRO cells (PRO-70AS cells) strongly decreased HSP70 expression and sensitized cell-free extracts to cytochrome c/dATPmediated activation of caspases. Subcutaneous injection of PRO-70AS cells induced tumors that rapidly regressed in syngeneic rats while they grew normally in nude mice. Syngeneic rats injected with PRO-70AS cells became protected against a further challenge with PRO cells. The tumor-speci®c immune response induced by HSP70-depleted PRO-70AS cells was associated with an increased rate of cell death in vivo. These PRO-70AS cells were also more sensitive to NO-mediated, caspasedependent, macrophage cytotoxicity in vivo. Altogether, these results indicate that reduced level of HSP70 expression in PRO-colon cancer cells results in the generation of a speci®c immune response by promoting cell death in vivo. Oncogene (2001) 20, 7478 ± 7485.
Introduction
Some tumor cells are immunogenic, as de®ned by their ability to induce a measurable, usually T-cell dependent, immune response, while others are not. Several studies have identi®ed a correlation between tumor cell immunogenicity and the expression of some heat shock proteins (HSPs) in both animal models (Melcher et al., 1998) and human cancers (Davido et al., 1992) . Various mechanisms have been proposed to account for the positive in¯uence of HSPs on tumor cell immunogenicity (Wells and Malkovsky, 2000) . One of these involves monocyte and granulocyte activation by HSPs released from dying tumor cells to generate an in¯ammatory response (Asea et al., 2000; Negulyaev et al., 1996) . Another mechanism involves the release of HSPs complexed with endogenous tumor peptides from dying tumor cells and the transfer of these antigenic peptides to antigen-presenting cells that, in turn, stimulate tumor-speci®c T-cells (Albert et al., 1998; Srivastava et al., 1998) . A third hypothesis suggests that over-expression of some HSPs could enhance the ability of tumor cells to process and present MHCclass I antigens directly to T-cells (Wells et al., 1998) . Based on the potential role of HSPs in inducing a tumor-speci®c immune response, clinical trials are now in progress to test HSP-peptide complexes isolated from each patient's tumor as a vaccine (Srivastava, 2000) .
The death of tumor cells can generate an ecient immunogenic stimulus and both apoptotic and necrotic tumor cells can be immunogenic under speci®c conditions Melcher et al., 1999) . For example, we have shown that inhibition of cell death by over-expression of the anti-apoptotic protein Bcl-2 could prevent immunogenicity and restore tumorigenicity of spontaneously regressive colon cancer tumors grown in syngeneic rats . Immunogenicity of various tumor cell lines when killed by using a suicide gene/prodrug system has been correlated with the expression of the inducible form of HSP70, which is consistent with a role for HSP70 released from tumor cells in inducing a speci®c immune response (Melcher et al., 1998; Todryk et al., 1999) . However, recent evidence has identi®ed a role for HSPs as negative regulators of apoptosis induced by a variety of stimuli (Xanthoudakis and Nicholson, 2000) . The protective function of these chaperones involves interactions with several components of the apoptotic machinery. We have shown that HSP27 binds to cytochrome c upon its release from the mitochondrion (Bruey et al., 2000) while others have demonstrated HSP70 and HSP90 binding to the adaptor molecule Apaf-1 (Beere et al., 2000; Pandey et al., 2000; Saleh et al., 2000) . In addition, we have shown the ability of HSP70 to exert a protective eect downstream of caspase-3 activation (Jaattela et al., 1998) and to prevent caspase-independent cell death by interacting with Apoptosis Inducing Factor (AIF) (Ravagnan et al., 2001) . In all cases, the consequence is an inhibition of the post-mitochondrial cell death pathways, suggesting that inducible HSP70, that behaves as an immunogenic protein when released from dying tumor cells , could also prevent occurrence of a speci®c immune response by inhibiting cell death.
To explore this latter hypothesis, we used the PRO rat colon cancer cell line that was established from a chemically-induced colon carcinoma in BDIX rats. Subcutaneous injection of PRO cells yields tumors that grow progressively, produce distant metastases and kill the hosts. Establishment of a PRO tumor was demonstrated to induce a tumor-speci®c immune tolerance in BDIX rats (Caignard et al., 1988) . In the present study, we used an anti-sense approach for studying the role of inducible HSP70 in PRO tumor development. Depletion of HSP70 led to a reduced tumorigenicity, increased immunogenicity in syngeneic animals and increased susceptibility of PRO cells to NO-mediated, caspase-dependent, macrophage cytotoxicity while having no eect on PRO cell tumorigenicity in nude mice. These data indicate that, at least in some tumor cell types, HSP70 expression rather than contributing to the generation of a speci®c immune response, prevents immunogenicity by inhibiting tumor cell death.
Results

Depletion of HSP70 enhances immunogenicity of colorectal cancer cells
To determine the role of inducible HSP70 in PROb rat colon cancer cell immunogenicity, we stably transfected these cells with hsp70 cDNA constructs in a sense or an anti-sense orientation. Cells transfected with an empty vector were used as controls. The expression of HSP70 was tested in G418-resistant cell pools before and after exposure to heat shock (428C for 1 h followed by incubation at 378C). In non-stressed cells, HSP70 protein level was about 10-fold higher in cells transfected with the sense construct (PRO-70S) and about threefold lower in those transfected with the anti-sense construct (PRO-70AS), as compared to control-transfected cells (PRO-C) (Figure 1 ) or parental PRO cells (not shown). Two hours after heat shock, HSP70 was strongly expressed in PRO-C cells (Figure 1) . Expression of the anti-sense construct eciently prevented stress-induced accumulation of HSP70 whose expression was 40-fold lower in stressed PRO-70AS than in stressed control cells. HSP70 expression was only slightly increased in stressed PRO-70S cells compared to stressed control cells (Figure 1 ). Transfection of these HSP70 constructs did not aect the expression of other major HSPs such as the constitutive HSC70 or HSP90 (Figure 1) . Further, altered HSP70 expression in these cells did not signi®cantly in¯uence tumor cell doubling time in culture (39+6.7 h).
We subsequently examined the in¯uence of HSP70 expression level on PRO cell tumorigenicity when injected subcutaneously (1x10 6 cells) into syngeneic BDIX rats. Both control and HSP70 over-expressing PRO-70S cells yielded progressive and lethal tumors that developed with similar kinetics. Conversely, HSP70 depleted PRO-70AS cells gave rise to tumors that progressed slightly during the ®rst 2 weeks. These small tumors, then, either stabilized or regressed almost completely by 4 ± 5 weeks after tumor cell injection (Figure 2 ).
To determine whether PRO-70AS tumor regression was associated with induction of a tumor speci®c immune response, rats in which PRO-70AS tumors had regressed were subsequently challenged with parental PRO cells. As control, rats bearing PRO-C and PRO-70S tumors were also re-challenged by injecting parental PRO cells on the contra-lateral side. While a second progressive tumor was observed in every animal initially injected with PRO-C or PRO-70S cells, none of the rats initially injected with PRO-70AS cells did develop a second tumor (Figure 3) .
When injected subcutaneously in immune-de®cient nude mice, the three cell populations, PRO-C, PRO-70S and PRO-70AS, gave rise to similar tumors ( Figure 4 ).
Selective depletion of HSP70 increases PRO cell sensitivity to apoptosis, both in vitro and in vivo Since HSP70 has been shown to interfere negatively with apoptosis by inhibiting caspase activation in various cell systems, we analysed the in¯uence of its depletion on activation of procaspase-3 and -9 in the presence of cytochrome c and dATP in nuclei and mitochondria cell-free extracts. After 60 min of incubation, caspase-3 and -9 activity increased by about twofold in the control cell extracts. This slight increase was inhibited when HSP70 was over-expressed ( Figure 5 ). However, both caspase activities increased by 4.5 ± 5-fold in acellular extracts from PRO-70AS in which HSP70 content was reduced ( Figure 5 ).
The role of HSP70 depletion on in vivo cell death and subsequent PRO cell tumor development was also examined. Hemalum-eosin staining of tumor sections was performed on day 2 after PRO-C, PRO-70S and PRO70AS cell injection in BDIX rats. Foci of dead cells were observed in HSP70 depleted PRO-70AS tumors while no such foci were observed in PRO-C or PRO-70S tumors ( Figure 6a ). By using a TUNEL assay, the percentage of positive cells remained lower than 2% in PRO-C and PRO-70S tumors while it was increased up to 21% in PRO-70AS tumors ( Figure 6b ).
Increased sensitivity of PRO-70AS cells to macrophage-mediated cytotoxicity
It has been established that macrophage in®ltration was a component of the host response to tumor rejection (Shrestha et al., 1999) . Immunohistochemical analyses of tumor sections obtained at day 2 after cell injection in BDIX rats showed ED2 + , OX17 + positive, activated macrophages to be prominent in the proximity of both PRO-C and PRO-70AS tumor cell nodules ( Figure 7a ). Recent observations from our group suggest that tumor-in®ltrating macrophages play a central role in tumor cell killing of PRO cells, when grafted in previously immunized rats (Bonnotte et al., 2001) . Therefore, we checked whether HSP70 expression could modulate tumor cell response to macrophage-mediated cytotoxicity in an ex vivo co-culture system. We observed that HSP70 depleted PRO-70AS cells were susceptible to the cytotoxic eect of activated peritoneal macrophages from naõÈ ve BDIX rats while the control PRO-C cells were not (Figure 7b ). To investigate the mechanistic aspects of this susceptibility to macrophage cytotoxicity, the PRO-70AS cells were co-cultured with activated macrophages in the presence of the pan-caspase-inhibitor z-VAD-fmk (5 mM), an anti TNFa antibody (5 mg/ml) and the NO-synthase inhibitor NMMA (0.5 mM). Macrophage mediated cytotoxicity of PRO-70AS was completely inhibited by low concentrations of z-VAD-fmk and NMMA while the anti-TNFa antibody failed to block this cytotoxic eect (Figure 7b ). These results suggest that an NO-mediated, caspase-dependent cell death is responsible for the macrophage induced cell death of PRO-70AS cells.
To further con®rm the role of NO in PRO-70AS cell susceptibility to macrophage mediated cell death, cells were cultured in the presence of TNFa (20 ng/ ml), GTN (500 mM), menadione (100 mM) and menadione+GTN. Neither TNFa, GTN or menadione alone were toxic for control PRO-C and the HSP70 depleted PRO-70AS cells. In contrast, the combination of GTN and menadione still unable to kill control PRO-C cells, was toxic for the HSP70 depleted PRO-70AS cells (Figure 7c ). These results suggest that HSP70 depletion sensitizes PRO cells to the NO/ROS combination.
To conclude, depletion of HSP70 results in an increased susceptibility of PRO cells to NO/ROSmediated, caspase-dependent, macrophage cytotoxicity.
Discussion
Two main functions have been identi®ed for inducible HSP70 expressed in tumor cells. Cytosolic HSP70 puri®ed from distinct tumors can elicit tumor-speci®c immunity by functioning as a vehicle for antigenic peptides (Srivastava et al., 1998) . On the other hand, it has been shown that the inducible HSP70 protein inhibits tumor cell apoptosis induced by a variety of stimuli (Jaattela, 1999) . The immunogenic and antiapoptotic functions of the protein may have opposite eects since tumor cell death has been shown to play a central role in inducing a speci®c immune response. The present study demonstrates that decreased expression of HSP70 by stable expression of an anti-sense construct sensitizes a rat colon carcinoma cell line to apoptosis and confers de novo immunogenicity to these cells. Conversely, neither down regulation of the protein nor its enforced expression had a signi®cant eect on tumor cells grown in nude mice. These observations suggest that the antiapoptotic properties of the chaperone protein predominate its pro-immune capacities when highly expressed in this colon carcinoma cell model.
In vivo studies have shown that HSP70 inhibits apoptosis upstream of caspase-3 activation (Li et al., 2000) by interacting with the adaptor molecule Apaf-1 (Beere et al., 2000; Saleh et al., 2000) . Accordingly, HSP70 depletion is shown to sensitize PRO cell-free extracts to caspase activation by cytochrome c. Several other molecular mechanisms have been involved in the antiapoptotic eect of HSP70, including inhibition of c-Jun N-terminal kinase (JNK) that contributes to cell death under certain conditions (Mosser et al., 1997; Park et al., 2001) ; interaction with AIF to prevent caspase-independent cell death (Ravagnan et al., 2001) ; prevention of cytochrome c release from the mitochondrion and refolding of proteins cleaved by eector caspases (Jaattela et al., 1998) . One or several of these mechanisms may account for the increased in vivo cell death induced by HSP70 depletion in PRO colon cancer cells.
Whereas parental PRO cells produce lethal tumors when injected into syngeneic rats, another clone isolated from the same initial carcinoma induces tumors that regress after 2 to 3 weeks and immunizes the host against a further challenge with PRO cells (Caignard et al., 1985) . We have shown previously that this immunogenic variant diers from PRO cells by its capacity to undergo apoptosis during the initial days following injection into syngeneic animals (Garrido et al., 1998) . Apoptosis of these cells was shown to release proteins that are engulfed by in¯ammatory cells in the tumor, then transported to lymph node T-cell areas where they induce a speci®c immune response leading to tumor rejection (Bonnotte (Garrido et al., 1998) antiapoptotic proteins decreases immunogenicity and increases tumorigenicity of this regressive clone. Based on these observations, we can speculate that increased immunogenicity of PRO cells with reduced HSP70 expression is a consequence of their enhanced sensitivity to cell death. Accordingly, histological examination identi®ed many foci of dead cells in PRO-70AS tumors at day 2 post-injection while no such foci were observed in tumors induced by control cells.
Inducible HSP70 was proposed to play a key role in dead cell immunogenicity by various mechanisms, e.g. by recruiting dendritic cells and expression of Th1 cytokines . The ability of PRO cells transfected with an hsp70 anti-sense construct to generate a speci®c immune response could indicate either that the residual inducible HSP70 in these cells is sucient to generate an immune response on cell death or that other signals that do not depend on HSP70 expression could stimulate an immune response. These latter signals could be HSPs other than HSP70 (Blachere and Srivastava, 1995) , caspaseprocessed peptides (Casciola-Rosen et al., 1995) , oligonucleosomes (Bell and Morrison, 1991) or others (Matzinger, 1998) . Whatever the mechanism, the present study demonstrates that depletion of HSP70 in PRO cells endows them with the ability to trigger a speci®c immune response since parental PRO cells do Figure 6 Selective depletion of HSP70 increases the sensitivity of PRO cells to in vivo cell death. Tumor sections were biopsied 2 days after s.c. injection of PRO-C, PRO-70S and PRO-70AS cells (a) These sections were stained with hemalum-eosin and (b) in vivo apoptosis was assessed by a TUNEL assay. The percentage+s.d. of apoptotic cells was determined from 300 cells in triplicate experiments not induce tumors in animals which have rejected PRO-70AS tumors. Conversely, enhanced expression of inducible HSP70 has no eect on PRO cell immunogenicity in syngeneic animals. Activated macrophages were identi®ed at the site of tumor cell injection into BDIX rats. In vivo studies have shown that activated macrophages exhibit tumor cell cytotoxicity (Hibbs et al., 1987) and that macrophage in®ltration is an important phenomenon of the host response to tumor rejection (Shrestha et al., 1999) . Further, we have recently observed that T-cell activated, tumor-in®ltrating macrophages play an important role in the elimination of parental PRO tumors engrafted in animals previously injected with their immunogenic clone (Bonnotte et al., 2001) . We show here that HSP70 depletion makes PRO cells susceptible to macrophage mediated cytolysis. Even though TNFa (Jaattela and Wissing, 1993) and NO (Hibbs et al., 1987) were both proposed as mediators of macrophage cytotoxicity towards tumor cells, macrophage mediated cytotoxicity of HSP70 depleted PRO cells appeared to be mainly dependent on NO. However, NO alone appears to be insucient for inducing tumor cell death in this model. It has been previously reported that the simultaneous production of NO and O 2 -gave rise to peroxynitrite (ONOO -) which is a more damaging oxidant than either of the two (Beckman and Koppenol, 1996) . In agreement with this observation, a combination of menadione (for production of O 2 -) and GTN (for synthesis of NO) was required to induce cell death of PRO-70AS cells ex vivo. Irrespective of the mechanism involved, the increased susceptibility of PRO-70AS cells to eector cells may generate a more potent immune signal by enhancing tumor cell death. In turn, dead cells may increase the recruitment of additional macrophages and this ampli®cation loop may lead to tumor regression.
Altogether, our data indicate that depletion of HSP70 induces PRO cell immunogenicity, probably as a consequence of increased susceptibility to spontaneous and macrophage-induced cell death, while further increasing HSP70 expression has no in¯uence on tumor growth and immune response. The balance between immunogenic (Blachere et al., 1997; Udono and Srivastava, 1993) and anti-apoptotic (Beere et al., 2000; Jaattela et al., 1998; Saleh et al., 2000) eects of this stress protein may account for the contradictory reports assessing a role for HSP70 expression in malignant cell tumorigenicity and immunogenicity (Jaattela, 1995; Kaur and Ralhan, 1995; Ralhan and Kaur, 1995; Seo et al., 1996; Volloch and Sherman, 1999; Wells and Malkovsky, 2000) . Limited expression of the protein, below an antiapoptotic level, could contribute to tumor cell immunogenicity when being released from dying cells (Kaur and Ralhan, 2000; Nylandsted et al., 2000) . Above a certain level of expression, which probably depends on the tumor cell type, the ability of the protein to suppress cell death could prevent it from playing a role in immune response, except when tumor cells are killed arti®cially, e.g. by transfer of a suicide gene system (Melcher et al., 1998) . These opposite eects of the protein may account for the contradictory results of clinical studies aiming to determine the prognostic value of HSP70 expression in human tumors. (b) PRO-C, PRO-70S and PRO-70AS cells were co-cultured at a 1 : 1 ratio with macrophages recovered from peritoneal cavity of naive rats and activated ex vivo with LPS (100 ng/ml). When indicated, antibody anti-TNFa (5 mg/ml), z-VAD-fmk (5 mM), or NG-monomethyl-L-arginine (NMMA, 0.5 mM), were added. After 48 h, tumor cell viability was measured by a crystal violet colorimetric assay (mean+s.d., n=4). (c) Selective depletion of HSP70 sensitizes PRO cells to GTN+menadione toxicity. PRO-C (closed bars) and PRO-70AS (open bars) cells were treated with TNFa (20 ng/ml), GTN (500 mM), menadione (100 mM) or GTN (500 mM)+menadione (100 mM) for 24 h. After 24 h, tumor cell viability was measured by a crystal violet colorimetric assay (mean+s.d., n=4)
Materials and methods
Cells, plasmids and transfections
Colorectal cancer PRO cells were grown as monolayers in a controlled atmosphere (378C, 5% CO 2 ) using Ham's F-10 medium (BioWhittaker, Fontenay-sous-bois, France) supplemented with 10% (v/v) fetal calf serum. PRO cells were stably transfected with a cDNA coding for HSP70, in the pcDNA3-Neo vector (Invitrogen). The anti-sense HSP70 construct was generated by inserting bases 475 ± 974 of the published human HSP70 sequence in antisense orientation downstream of a CMV promotor of the same vector. Transfections were performed by using the Superfect reagent. Exponentially growing PRO cells were transfected with 5 mg DNA vectors mixed with 20 ml Superfect reagent (Quiagen GmbH, Germany). Transfected cells were selected with G418 (Sigma-Aldrich) and pools of G418 resistant cells analysed for HSP70 expression by immunoblotting.
Immunoblotting
The mouse anti-human HSP70 (SPA-810) and HSP90 (SPA830) monoclonal antibodies were purchased from StressGen (Victoria, Canada) and the cognate HSC70 speci®c (B-6) antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, USA). Immunoblots were performed as described (Bruey et al., 2000) . Brie¯y, whole cell extracts were prepared by lysing the cells with 2% SDS, 137 mM NaCl, 2.7 mM KCl, 8 mM Na 2 HPO 4 , and NaCl/P i (pH 7.4) at 688C for 5 min. Protein concentration was measured in the supernatant by using the micro BCA protein assay (Pierce, Asnieres, France). Proteins were separated in a 8 ± 12% SDS ± polyacrylamide gel and electroblotted to PVDF membranes (BioRad, Ivry sur Seine, France). After blocking non-speci®c binding sites with 5% non-fat milk in T-PBS (PBS, Tween 20 0.1%), blots were incubated with speci®c antibodies, washed in T-PBS, incubated 30 min at room temperature with horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson ImmunoResearch Laboratories, West Grove, PE) and revealed following the ECL Western blotting analysis procedure (Amersham, Les Ullis, France). Autoradiographs were recorded onto X-Omat AR ®lms (Eastman Kodak Co, Rochester). A Biopro®l system (Vilber Lourmat, France) was used for quanti®cation. The analysis was performed within the range of proportionality of the ®lm. All the Western analyses were repeated three times.
Activation of cell free apoptosis
Cell-free extracts (5 ± 10 mg/ml protein), prepared as described (Garrido et al., 1999) , were incubated with 5 mM horse heart cytochrome c (Sigma Aldrich, Steinheim, Germany) and 1 mM dATP (Pharmaica, Orsay, France). Caspase-3 and Caspase-9 activities were measured by the cleavage of the¯uorometric substrates DEVD-AFC and LEHD-AFC respectively (Calbiochem, San Diego, CA, USA). AFC released from the substrates were excited at 400 nm. Emission was measured at 505 nm.
Cell growth analysis in vitro 4x10
4 tumor cells were plated in tissue culture dishes on day 0. At indicated times, cells were trypsinized, diluted in a known volume of medium and counted using a hemocytometer. The results obtained represent the mean of four independent determinations of the cell number for each time point.
Tumor growth analysis in vivo
Exponentially growing HSP70S-, HSP70AS-, control-transfected PRO cells as well as parental PRO cells were harvested, washed in PBS, and resuspended to a concentration of 10 6 cells in 200 ml of Ham's F-10 medium. The cells were injected s.c. into the anterior thoracic wall of syngeneic BDIX rats or in the back of nude mice. Tumor volume was evaluated weekly, using a caliper to measure two perpendicular diameters.
Histologic study of the tumor cell injection site Animals were killed 48 h after cell injection. The site of tumor cell injection was resected and either ®xed in formaldehyde (4% in PBS) and embedded in paran or embedded in Tissue-Tek (Miles, Elkhart, IN, USA) and snap-frozen in methylbutane that had been cooled in liquid nitrogen. Apoptotic cells were labeled on 5 mM paran-embedded sections according to the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick-end labeling (TUNEL) procedure using terminal transferase (Boehringer Mannheim, Germany), biotin-16-2'-deoxyuridine-5'-triohosphate (Boehringer Mannheim) and streptavidin-peroxidase (Amersham, Les Ullis, France), followed by hemalum staining. Tumor cells on slides stained with hemalum-eosin were distinguished from in¯ammatory cells according to their size, their large nucleus with oversized nucleoli, and their assembly in nodules. The presence of tumor cells was con®rmed by immunolabeling PRO-b cells with the monoclonal Ab 12C ). An immunohistochemical study of tumor-in®ltrating in¯ammatory cells was performed on acetone-®xed 5 mM cryostat sections. Mouse mAbs to rat monocytes (ED2) and class II MHC (OX-17) were obtained from Serotec (Oxford, UK). Sections were incubated with mAbs and biotinylated sheep Ab to mouse IgG (Amersham, Les Ullis, France), subsequently incubated with streptavidin-peroxidase, and stained with aminoethylcarbazole.
Cytotoxicity assays
Macrophage-mediated cytotoxicity was measured using peritoneal macrophages harvested from naive BDIX rats after intra-peritoneal injection of 10 ml serum-free HAM's F-10 medium. 10 5 adherent cells were plated on to 96-well culture plates in complete medium along with an equal number of target cells (PRO-C, PRO-70S, PRO-70AS). Macrophages were activated with the E. coli (serotype 0128:B12) endotoxin LPS (Sigma Aldrich, Steinheim, Germany). Cells were co-cultured in the presence or absence of z-VAD-fmk (5 mM) (RandD systems, Great Britain), NG-monomethyl-L-arginine (NMMA, 0.5 mM) (Sigma Aldrich, Steinheim, Germany), and anti-TNFa (5 mg/ml) (RandD systems, Great Britain) for 48 h. The number or residual attached cells was measured by a crystal violet colorimetric assay.
To measure the cytotoxicity of TNFa (20 ng/ml) (Pepro Tech Inc., New Jersey, USA), NO donor Glycerol trinitrate (GTN, 500 mM) (Sigma Aldrich, Steinheim, Germany), and vitamin K 3 (menadione, 100 mM) (Sigma Aldrich, Steinheim, Germany), 5X10 6 cells/well were seeded on to 96 well plates. The number of viable cells after treatment was measured by a crystal violet colorimetric assay.
